T. Rowe Price Investment Management, Inc. Immunome Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $164 Billion
- Q3 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Immunome Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 8,418,163 shares of IMNM stock, worth $144 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
8,418,163
Previous 8,275,257
1.73%
Holding current value
$144 Million
Previous $77 Million
28.09%
% of portfolio
0.06%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding IMNM
# of Institutions
166Shares Held
71.5MCall Options Held
325KPut Options Held
4.31M-
Redmile Group, LLC San Francisco, CA5.02MShares$86.1 Million6.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$83.9 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.82MShares$82.7 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$69.9 Million3.55% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$64.4 Million0.0% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $208M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...